- LSD (13-26µg) significantly increases neural complexity compared to THC (7.5-15mg) and methamphetamine (10-20mg), which do not show the same effect.
- While LSD reduces delta and theta wave power, THC decreases alpha power and methamphetamine increases it, indicating differing impacts on brainwave activity.
- Increased neural complexity was not linked to subjective drug effects, highlighting that elevated complexity does not equate to altered states of consciousness.
Overview of the Research
In light of increasing public interest in microdosing psychedelics, the authors of this re-analysis sought to evaluate the effects of low doses of LSD, THC, and methamphetamine on neural complexity among healthy volunteers. Using a within-subjects design over three laboratory visits, participants were given different substances, and resting state EEG data was collected to analyze changes in neural complexity and spectral power. The study involved 73 healthy volunteers in total, divided among the three drugs, with the findings revealing significant insights regarding how each substance affects brain function.
Methodology in Detail
Three separate studies were conducted at the University of Chicago’s Human Behavioral Pharmacology Laboratory from 2020 to 2022. Healthy adults aged between 18 and 35 were recruited and rigorously screened to exclude those with a history of severe psychiatric disorders or substance abuse. Participants were instructed to abstain from any prohibited substances before each session. The doses of drugs administered were specifically designed to assess neural complexity without leading to altered consciousness.
Drug Administration and Assessments
LSD was administered in liquid form, sublingually, with participants receiving either 13 or 26 µg. THC was provided in capsule form, while methamphetamine was prepared to mimic the subjective effects produced by its smoked form. Various tools, including the Drug Effects Questionnaire and the 5 Dimensions of Altered States of Consciousness (5D-ASC) questionnaire, were used to evaluate the subjective effects of the drugs during each session. EEG measurements were conducted 90-120 minutes following drug administration to assess neural complexity and oscillatory power across frequency bands.
Results Highlighted
The findings show that low doses of LSD distinctly raised Limpel-Ziv complexity, an indicator of neural complexity, while neither THC nor methamphetamine exhibited similar effects. Additionally, LSD reduced low-frequency power and increased high-frequency gamma power. The relationship between self-reported mood states and neural complexity indicated that LSD’s low-frequency desynchronization may correlate with feelings of drug effects and anxiety levels, reinforcing the unique properties of LSD compared to the other substances tested. Interestingly, even though participants noticed changes after LSD administration, responses on the 5D-ASC suggesting altered states did not rise, underlining that brain complexity doesn’t necessarily correlate with subjective experiences of consciousness.
Discussion and Implications
The authors concluded that low doses of LSD can increase neural complexity, which could enhance cognitive performance and clinical outcomes in psychiatric treatment. However, they emphasize that such acute increases in complexity do not directly correlate with subjective feelings of altered consciousness, providing critical insights into how neural complexity relates to consciousness and the ongoing exploration of psychedelics’ therapeutic potential. These distinctions underscore the need for further research, particularly in understanding the mechanisms driving these outcomes and identifying objective markers for therapeutic effects.
Read the full paper summary on Blossom.

